… After summarizing the recent updates in PPGL, we provide a synthesis for molecular biology,
clinical, biochemical, and imaging classifications in 2017. Relevant examples of how these …

We report a comprehensive molecular characterization of pheochromocytomas and
paragangliomas (PCCs/PGLs), a rare tumor type. Multi-platform integration revealed that PCCs/…

… and molecular pathogenesis of PPGLs, including pathogenetic mechanisms, genetic susceptibility
and molecular classification. … Current and potential molecular prognosticators are also …

… Schematic Please check and approve the edit made in the figure caption representation of
the pheochromocytoma/paraganglioma classification in cluster 1 and cluster 2 based on the …

… Pheochromocytomas and paragangliomas (collectively termed PPGLs) are neuroendocrine
… required for detection of recurrent tumors and choice of molecular imaging agent (7–9). …

… AMH in MEN2 patients have the same molecular markers as pheochromocytomas [44],
leading to the suggestion that the term nodular hyperplasia be dropped and replaced with micro-…

… The tumours were classified as well (score= 0-2), moderately (score … molecular markers
have been proposed to affect the survival of patients with pheochromocytoma or paragangliomas …

… in paragangliomas can … paragangliomas is 18F-fluorodeoxyglucose (18F-FDG). This review
will first describe conventional scintigraphic exams that are used for imaging paragangliomas…

… Neuroendocrine tumors arising from the adrenal medulla and extra-adrenal ganglia are
called pheochromocytomas and paragangliomas (PCCs/PGLs), respectively. PCCs/PGLs are …

… catecholamine phenotype and molecular profiling correlates … [7], PPGLs have been classified
into either benign or malignant … The lack of a histological, molecular, or genetic criteria that …